Conduit Pharmaceuticals Profit Margin

The latest profit margin for CDT is 12.85% as of June 2026. That compares with 6.29% in the prior-year period — up 104.5% year over year. That is below the sector sector average of 21.44%. Investors often review this figure alongside Conduit Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Over the past year, CDT's profit margin moved from 6.29% to 12.85% — a 104.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Conduit Pharmaceuticals's valuation or profitability profile.

Against its sector companies, CDT currently prints 12.85% for profit margin, while the sector average sits near 21.44%. That is roughly 40.0% below the sector mean. Large gaps often invite a closer look at Conduit Pharmaceuticals's growth, margins, and balance sheet.

Profit Margin shows how effectively Conduit Pharmaceuticals converts resources into returns. At 12.85%, CDT may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 6.29% in the prior-year period — up 104.5% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting CDT's profit margin (12.85%), review year-over-year change from 6.29%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.